Evaluation of thrombocytopenia

Last reviewed: 11 Aug 2025
Last updated: 02 Sep 2025

Summary

Differentials

Common

  • Leukemia
  • Metastatic malignancy
  • Hodgkin lymphoma
  • Non-Hodgkin lymphoma
  • Miliary tuberculosis
  • Disseminated intravascular coagulation (DIC)
  • Post-transfusion
  • Hemolysis, elevated liver enzymes, low platelet count (HELLP)
  • Cardiopulmonary bypass
  • Immune thrombocytopenia (ITP)
  • Systemic lupus erythematosus (SLE)
  • Rheumatoid arthritis
  • Antiphospholipid syndrome
  • HIV/AIDS
  • Malaria
  • Dengue fever
  • Zika virus infection
  • Cytomegalovirus (CMV)
  • Infectious mononucleosis
  • COVID-19
  • Parvovirus B19
  • Sepsis
  • Heparin-induced thrombocytopenia (HIT)
  • Antimalarials, antiseizure drugs, antibiotics, or chemotherapies
  • Alcohol ingestion
  • B12 deficiency
  • Folate deficiency
  • Gestational thrombocytopenia
  • Cirrhosis
Full details

Uncommon

  • Multiple myeloma
  • Bone marrow fibrosis
  • Thrombotic thrombocytopenic purpura (TTP)
  • Hemolytic uremic syndrome (HUS)
  • Sarcoidosis
  • Cyclic thrombocytopenia
  • Wiskott-Aldrich syndrome
  • MYH9-related disorders, including May-Hegglin anomaly
  • Bernard-Soulier syndrome
  • Gaucher disease
  • Hashimoto thyroiditis
  • Aplastic anemia
  • Vaccinations
  • Paroxysmal nocturnal hemoglobinuria (PNH)
  • Pseudothrombocytopenia
  • Familial platelet disorder with germline RUNX1 mutation
  • Thrombocytopenia due to germline ANKRD26 mutation
  • Thrombocytopenia due to germline ETV6 mutation
Full details

Contributors

Authors

Hanny Al-Samkari, MD

Division of Hematology/Oncology

Peggy S. Blitz Endowed Chair in Hematology/Oncology

Massachusetts General Hospital

Associate Professor of Medicine

Harvard Medical School

Boston

MA

Disclosures

HA has received fees for consulting from Agios, Amgen, argenx, Alpine, Alnylam, Sobi, Pharmacosmos, Novartis and Sanofi; and received research funding to their institution from Amgen, Agios, Sobi, Novartis, and Vaderis.

Acknowledgements

Dr Hanny Al-Samkari would like to gratefully acknowledge Dr Julia T. Geyer and Dr Alan E. Lichtin, previous contributors to this topic. JTG declares that she has no competing interests. AEL is on an advisory board and has received research support from Amgen.

Peer reviewers

Roger M. Lyons, MD, FACP

Clinical Professor of Medicine

University of Texas Health Science Center

San Antonio

Cancer Care Network of South Texas

San Antonio

TX

Disclosures

RML declares that he has no competing interests.

Jeffrey S. Wasser, MD

Clinical Assistant Professor of Medicine

University of Connecticut School of Medicine

Farmington

CT

Disclosures

JSW has received research support from Amgen, Ligand Pharmaceuticals, and MGI Pharma for clinical studies in immune thrombocytopenic purpura.

Keith R. McCrae, MD

Professor of Medicine

Case Western Reserve University School of Medicine

Cleveland

OH

Disclosures

KRM declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019 Nov 26;3(22):3780-817.Full text  Abstract

Cines DB, Levine LD. Thrombocytopenia in pregnancy. Blood. 2017 Nov 23;130(21):2271-7.Full text  Abstract

American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 207: thrombocytopenia in pregnancy. Obstet Gynecol. 2019 Mar (reaffirmed 2022);133(3):e181-93. Abstract

Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019 Sep 5;381(10):945-55.Full text  Abstract

Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Full text

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Use of this content is subject to our disclaimer